Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL04
- Pharmacological subgroupL04A
- Chemical subgroupL04AB
- Chemical substanceL04AB04Adalimumab
Where it is registered
Each register with its number of medicines and a few of them.
United States
FDA · 65 medicines
- Abrilada10MG/0.2ML, 20MG/0.4ML, 40MG/0.8ML · injectable · Pfizer INC
- Amjevita20MG/0.4ML, 40MG/0.8ML · injectable · Amgen INC
- Cyltezo40MG/0.8ML · injectable · Boehringer Ingelheim
- Hadlima40MG/0.8ML · injectable · Samsung Bioepis Co LTD
Netherlands
CBG-MEB · 51 medicines




